SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
897Sigma-Aldrich And MorphoSys AG To Collaborate For Developing And Distributing ReGermanecki-2/27/2008
896Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexanigel bates-2/26/2008
895MorphoSys Receives CTA Approval to Initiate Phase 1 Clinical Study for MOR103 PrGermanecki-2/21/2008
894MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel AnGermanecki-2/21/2008
893MorphoSys Discloses GM-CSF as Target of MOR103 Program 01/16/2008 at 07:30 AM Germanecki-1/16/2008
892BioInvent and Genentech Initiate Phase I Clinical Trial for BI-204, a potential B O Trust-1/15/2008
891coooooooooooooooooooooooool. always had a serotec reagent or two around, sometiscaram(o)uche-1/9/2008
890NIDDK Scientists Detect New Epitope on HIV-1 Protein gp41 Using AbD Serotec-geneGermanecki-1/9/2008
889MorphoSys Files Clinical Trial Application to Initiate First Phase 1 Clinical StGermanecki-12/28/2007
888MorphoSys Broadens Scope of Collaboration with GeneFrontier 12/10/2007 at 07:38Germanecki-12/10/2007
887MorphoSys and Novartis Forge New Strategic Alliance to Establish Innovative Thernigel bates-12/3/2007
886Here's another: siliconinvestor.comDewDiligence_on_SI-11/28/2007
885Haven't seen privately held Agensys talked of here. They just got munched ftuck-11/28/2007
884Dyax and MorphoSys Sign License Agreement on Antibody-Related Patents 20.11.20Germanecki-11/20/2007
883MorphoSys Announces Development of New Antibody Platform Technology MARTINSRIEDGermanecki-11/20/2007
882Nigel; From today's news and since you invite "any" discussion on Steve Lokness-10/30/2007
881MorphoSys Reports Nine Months 2007 Results 10/25/2007 at 07:30 AM MorphoSys AGermanecki-10/25/2007
880MorphoSys Enters Therapeutic Research Collaboration on Novel Target Molecule witGermanecki-10/8/2007
879Johnson&Johnson Daughter Centocor was the third mAb in clinic with MorphosysGermanecki-10/4/2007
878AVEO Pharmaceuticals to Utilize Peptech's Breakthrough Technology to 'Hunigel bates-10/2/2007
877MorphoSys Announces Clinical Milestone in Antibody Program -- Fourth HuCAL-basedGermanecki-9/19/2007
876ABLYNX AND BOEHRINGER INGELHEIM ANNOUNCE MAJOR GLOBAL STRATEGIC ALLIANCE TO DISCnigel bates-9/7/2007
875(CAT/DYAX) Interesting... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQnigel bates-8/9/2007
874MorphoSys Reports Six Months 2007 Results07/30/2007 at 07:30 AM MorphoSys AG (Germanecki-8/2/2007
873>>Peptech primes itself for trade sale<< <i>Didn't happennigel bates-7/10/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News